This time on #NICEtalks, we discuss teplizumab for NHS use, the first treatment to delay the onset of symptomatic type 1 diabetes by an average of nearly three years:
NICE
@NICEComms
Official feed of NICE - National Institute for Health and Care Excellence. We produce evidence-based health and social care guidance. Tweets by the comms team.
![Janet sits while clinician listens to her heart with stethoscope. Overlaid text reads: Janet, 80 who has heart failure says: “If the device triggers [any unusual data recordings] I get a phone call from a nurse, who asks me how I am. It is quite reassuring being monitored and if anything goes wrong, there’s someone at the other end of the device to put things right.”](https://pbs.twimg.com/media/HMx49OQXYAAcjqo?format=webp&name=medium)
